| Financial Year |
March 31 2023 |
| Monetary Funds |
174,771,096.01 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
40,028,714.09 |
| Accounts Receivable |
255,268,016.10 |
| Advances to Suppliers |
34,910,670.18 |
| Other Receivables |
55,057,134.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
243,713,300.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,101,384.49 |
| Total Current Assets |
849,879,449.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,674,132.35 |
| Investment Properties |
-- |
| Fixed Assetes |
412,521,625.41 |
| Under-construction Projects |
124,631,763.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
82,961,323.74 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,328,457.01 |
| Deferred Income Tax Assets |
46,116,396.41 |
| Other Non-Current Assets |
3,391,140.00 |
| Sub-Total of Non-Current Assets |
793,491,150.76 |
| Total Assets |
1,643,370,599.90 |
| Short-Term Loans |
259,326,568.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
171,771,649.16 |
| Accounts Payable |
346,230,495.67 |
| Accounts Received In Advance |
543,175.65 |
| Employee Compensation Payable |
17,369,193.88 |
| Taxes Payable |
8,095,316.84 |
| Interest Payable |
-- |
| Dividend Payable |
396,518.99 |
| Other payables |
62,033,817.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
45,542,796.45 |
| Other Current Liabilities |
24,335,301.49 |
| Sub-Total of Current Liabilities |
941,535,288.85 |
| Long-term Loans |
121,066,094.48 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
405,160.95 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,135,657.00 |
| Deferred Income Tax Liabilities |
7,368,796.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
284,042,319.09 |
| Total Liabilities |
1,225,577,607.94 |
| Paid-In Capital(Or Share Stock) |
160,020,000.00 |
| Capital Surplus |
455,943,435.21 |
| Surplus Reserve |
29,846,242.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-382,745,125.73 |
| Minority Stockholder's Interest |
155,492,204.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
262,300,787.83 |
| Owner's Equity（Stockholder's Equity） |
417,792,991.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,643,370,599.90 |
